Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Abstract Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood. This case‐control study was conducted to identify pneumonitis risk factors in patients treated with anti‐PD1 monoclonal antibodies (m...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2018-08-01
coleção:	Cancer Medicine
Assuntos:	anti‐PD‐1 case‐control study pneumonitis risk factors
Acesso em linha:	https://doi.org/10.1002/cam4.1579
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!